0001225208-21-002258.txt : 20210211
0001225208-21-002258.hdr.sgml : 20210211
20210211180438
ACCESSION NUMBER: 0001225208-21-002258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Joseph Michael
CENTRAL INDEX KEY: 0001484186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 21621405
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2021-02-10
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001484186
Fitzgerald Joseph Michael
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & Pres, Interven Cardio
Common Stock
2021-02-08
5
G
0
3040.0000
0.0000
D
231603.0000
D
Common Stock
2021-02-10
4
A
0
17995.0000
0.0000
A
249598.0000
D
Common Stock
2021-02-10
4
F
0
8881.0000
38.8500
D
240717.0000
D
Common Stock
2021-02-08
5
G
0
1520.0000
0.0000
A
6038.0000
I
By Children
Common Stock
68312.0000
I
By 401(k)
This transaction involved a gift of securities by the reporting person to his children, two of whom share reporting person's household.
Mr. Fitzgerald's holdings include 15 shares of common stock, which, due to an administrative error, had not been previously reported.
On February 15, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2020 and subject to the completion of the concurrent three-year individual service period. On February 9, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. Shares held by one of his children, who is no longer considered a dependent, have been removed from this report.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
/s/ Scott G. Hodgdon, Attorney-in-Fact
2021-02-11